Association of H. pylori Infection with Insulin Resistance and Metabolic Syndrome Among Lebanese Adults

Helicobacter

Volumn 17, Issue 6, 2012, Pages 444-451

  Naja, Farah ^a   Nasreddine, Lara ^a   Hwalla, Nahla ^a   Moghames, Patricia ^a   Shoaib, Hikma ^a   Fatfat, Maamoun ^a   Sibai, Abla ^a   Gali Muhtasib, Hala ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Cardio vascular risk factor; Epidemiology; Prevalence rate

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN G ANTIBODY; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIBODY TITER; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CHOLESTEROL BLOOD LEVEL; CROWDING; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEBANON; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SEROPREVALENCE; SOCIOECONOMICS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; ANTIBODIES, BACTERIAL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; INSULIN RESISTANCE; LEBANON; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 84867702976     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00970.x     Document Type: Article

References (45)

1. Haffner SM, Miettinen H Insulin resistance implications for type II diabetes mellitus and coronary heart disease. Am J Med 1997;103:152-62.
2. Beckman JA, Creager MA, Libby P Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002;287:2570-81.
3. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-5.
4. Sibai A, Obeid O, Batal M, et al. Prevalence and correlates of metabolic syndrome in an adult Lebanese population. CVD Prev Control 2008;3:83-90.
5. Chedid R, Gannage-Yared MH, Khalife S, et al. Impact of different metabolic syndrome classifications on the metabolic syndrome prevalence in a young Middle Eastern population. Metabolism 2009;58:746-52.
6. Naja F, Nasreddine L, Itani L, et al. Association between dietary patterns and the risk of metabolic syndrome among Lebanese adults. Eur J Nutr 2011; DOI: 10.1007/500394-011-0291-3. [Epub ahead of print].
7. Helfand M, Buckley DI, Freeman M, et al. Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:496-507.
8. Goh KL, Chan WK, Shiota S, et al. Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 2011;16(Suppl 1):1-9.
9. Hussein NR Helicobacter pylori and gastric cancer in the Middle East: a new enigma? World J Gastroenterol 2010;16:3226-34.
10. Naous A, Al-Tannir M, Naja Z, et al. Fecoprevalence and determinants of Helicobacter pylori infection among asymptomatic children in Lebanon. J Med Liban 2007;55:138-44.
11. Sharara AI, Abdul-Baki H, El Hajj I, et al. Association of gastroduodenal disease phenotype with ABO blood group and Helicobacter pylori virulence-specific serotypes. Dig Liver Dis 2006;38:829-33.
12. Kalaajieh WK, Chbani-Rima A, Kassab TF, et al. ++Helicobacter pylori infection in North Lebanon. Sante 2000;10:31-5.
13. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-6.
14. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann Intern Med 1999;131:88-95.
15. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991;302:1302-5.
16. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 2008;103:3005-10.
17. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007;121:229-38.
18. Begue RE, Mirza A, Compton T, et al. Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus. Pediatrics 1999;103:e83.
19. Gunji T, Matsuhashi N, Sato H, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009;14:144-50.
20. Gen R, Demir M, Ataseven H Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 2010;103:190-6.
21. Aydemir S, Bayraktaroglu T, Sert M, et al. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005;50:2090-3.
22. Eshraghian A, Hashemi SA, Hamidian Jahromi A, et al. Helicobacter pylori infection as a risk factor for insulin resistance. Dig Dis Sci 2009;54:1966-70.
23. Aslan M, Horoz M, Nazligul Y, et al. Insulin resistance in H. pylori infection and its association with oxidative stress. World J Gastroenterol 2006;12:6865-8.
24. Manolakis A, Kapsoritakis AN, Potamianos SP A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease. Helicobacter 2007;12:287-97.
25. Christodoulou DK, Milionis HJ, Pappa P, et al. Association of Helicobacter pylori infection with cardiovascular disease-is it just a myth? Eur J Intern Med 2011;22:191-4.
26. Dore MP, Bilotta M, Malaty HM, et al. Diabetes mellitus and Helicobacter pylori infection. Nutrition 2000;16:407-10.
27. Wang SZ, Shi YN, Zhao J, et al. Effects of Helicobacter pylori on blood glucose fluctuation in type 2 diabetic patients. Zhonghua Yi Xue Za Zhi 2009;89:958-61.
28. Gillum RF Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the Third National Health and Nutrition Examination Survey. J Natl Med Assoc 2004;96:1470-6.
29. Schottker B, Adamu MA, Weck MN, et al. Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis 2012;220:569-74.
30. Central Administration for Statistics and UNDP. Living Conditions of Households The National Survey of Household Living Conditions 2004. Lebanon: Lebanese Republic Ministry of Social Affairs, 2006'114-5.
31. Freedman J What is crowding. In: Freedman J, ed. Crowding and Behavior. San Francisco: WH Freeman, 1975;1-11.
32. Baum A, Epstein Y Crowding: historical and contemporary trends in crowding research. In: Baum A, Epstein Y, eds. Human Response to Crowding. Hillsdale, NJ: L Earlbaum, 1978;3-22.
33. Uday J Introduction. In: Uday J, ed. The Psychological Consequences of Crowding. New Delhi, India: Sage, 1987;15-46.
34. Melki IS, Beydoun HA, Khogali M, et al. Household crowding index: a correlate of socioeconomic status and inter-pregnancy spacing in an urban setting. J Epidemiol Community Health 2004;58:476-80.
35. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
36. Naja F, Kreiger N, Sullivan T Helicobacter pylori infection in Ontario: prevalence and risk factors. Can J Gastroenterol 2007;21:501-6.
37. Danesh J, Peto R Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998;316:1130-2.
38. Suzuki H, Franceschi F, Nishizawa T, et al. Extragastric manifestations of Helicobacter pylori infection. Helicobacter 2011;16(Suppl 1):65-9.
39. Lu YH, Yen HW, Lin TH, et al. Changes of coronary risk factors after eradication of Helicobacter pylori infection. Kaohsiung J Med Sci 2002;18:266-72.
40. Huang B, Chen Y, Xie Q, et al. CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease. Dig Dis Sci 2011;56:109-14.
41. deFoneska A, Kaunitz JD Gastroduodenal mucosal defense. Curr Opin Gastroenterol 2010;26:604-10.
42. Woodward M, Morrison C, McColl K An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 2000;53:175-81.
43. Murray LJ, McCrum EE, Evans AE, et al. Epidemiology of Helicobacter pylori infection among 4742 randomly selected subjects from Northern Ireland. Int J Epidemiol 1997;26:880-7.
44. Frenck RW Jr, Clemens J Helicobacter in the developing world. Microbes Infect 2003;5:705-13.
45. Borai A, Livingstone C, Kaddam I, et al. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol 2011;11:158-68.